A 3D virtual model of the PKMYT1–PROTAC–CRBN ternary complex depicting how Insilico Medicine’s bifunctional proteolysis-targeting chimera (PROTAC) D16-M1P2 (shown in yellow) inhibits ...
London biotech startup Ternary Therapeutics has raised £3.6m to scale its AI-powered platform designed to engineer molecular ...
This article and associated images are based on a poster originally authored by Leif, F., Hsia, O., Cowan, A.D., Iso, K. and Ciulli, A. and presented at ELRIG Drug Discovery 2025 in affiliation with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results